SERPINA1 and breast cancer: Although few studies have evaluated the participation of α1-AT with BC, it is possible that in the future it could be considered as a marker for prediction and tumor progression with clinical applications because our findings are compatible with those described in previous studies which have reported differences in the concentration of α1-AT between HW and patients with BC.